Skip to content

DOKTER J. BURM

Active
Private limited companyfounded 1998active for 27 yearsFerdinand Lousbergskaai 49, 9000 Gent, BelgiumKBO/BCE: BE 0464.955.147
Summary

DOKTER J. BURM has been active since 1998 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €300,539 and a net result of €22,194. Equity is growing by about 11% per year across the filed financial years. Its solvency ranks better than 53% of 20,612 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
DOKTER J. BURMActiveChecked score 90/100
Risk analysis ReportCompare

Overview

Activity
General medical practice
NACE 86210
1 site
Size
€453,594total assets 2025
Equity
€300,539
Profit
€22,194
Turnover not published (micro format)
Financial health
90 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 25 days early3 deeds in the Belgian Official Gazette
Why 90lowers riskSector: Human health activities (NACE 86)Size: total assets €453,594Figures for financial year 2025 (filed 06-07-2026)Founded in 1998Show the evidence

Checked score

Score 2025
90 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 23% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Average
Solvency 91-9
equity 66.3% of total assets
Liquidity 48-4
short-term debt 33.7% · cash 10.6%
Profitability 50-23
return on assets 4.9%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,124 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026highest value 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.89, compared with 50.45 in 2024, above the usual 1.5; short-term debt: 33.7% and cash: 10.6% of total assets), and 33.7% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 54% on solvency, 16% on liquidity, 8% on profitability and 13% on growth.

The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €453,594
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 06-07-2026)
NBB · annual accounts
lowers risk · Founded in 1998
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-07-2026, 25 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
25 days early
2024
30 days early
2023
2 days early
2022
26 days early
2021
24 days early
2020
117 days late
2019
113 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 18 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 6 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
27-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Weakest financial yearnet €20,131 ▼54.7%

Key points

  • Caution: Equity fell in 2025from €577,712 to €300,539 ▼ 48.0% View
  • Positive: 8 profitable years in a rowprofit 2025: €22,194 8 years View
  • Positive: Filed on time since financial year 2021accounts within the deadline every year 5 years View

By topic

Financials

Financial year
2025
Total assets
€453,594
Profit
€22,194
Solvency
66.3%
Total assets▼ 23.0%
Net result
20182025
Go to Financials

Timeline

Events
31
Since
2000
Next accounts
by 31-07-2027
  1. 29-07-2024Annual accounts filed
  2. 05-07-2023Annual accounts filed
  3. 31-12-2022Liquidity more than 5 times
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
General medical practiceNACE 86210
Founded
22-12-1998
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about DOKTER J. BURM

What is the company number of DOKTER J. BURM?
0464.955.147. In Belgium the VAT number is the company number with BE in front: BE 0464.955.147.
Where is DOKTER J. BURM based?
The registered office is at Ferdinand Lousbergskaai 49, 9000 Gent.Company details
What does DOKTER J. BURM do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DOKTER J. BURM?
Private limited company (BV).
When was DOKTER J. BURM founded?
On 22-12-1998.
Is DOKTER J. BURM still active?
Yes, DOKTER J. BURM is an active enterprise in the KBO register.
What is the turnover of DOKTER J. BURM?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is DOKTER J. BURM profitable?
In financial year 2025, DOKTER J. BURM made a profit of €22,194.
Where can I find the annual accounts of DOKTER J. BURM?
DOKTER J. BURM filed 27 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DOKTER J. BURM due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to DOKTER J. BURM

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure